Why this Maryland biotech furloughed 130 workers in Michigan
The U.S. government's ordering of an anthrax vaccine is necessary for the company to continue operating that facility. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 27, 2024 Category: Pharmaceuticals Authors: Sara Gilgore Source Type: news

Emergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million to Supply BioThrax ® (Anthrax Vaccine Adsorbed) to the U.S. Department of Defense
GAITHERSBURG, Md., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. EBS today announced that it has secured an indefinite-delivery, indefinite-quantity (IDIQ) procurement contract with a maximum value up to $235.8 million to supply BioThrax® (Anthrax Vaccine Adsorbed) for use by all…#gaithersburg #biothrax #paulwilliams #linkedin (Source: Reuters: Health)
Source: Reuters: Health - January 11, 2024 Category: Consumer Health News Source Type: news

The White House ’ s Latest Move to Rein in Drug Prices
Each year, the U.S. government spends over $100 billion investing in the research and development of new technologies, with pharmaceutical companies being among the chief beneficiaries of this research. These public-private partnerships have led to some of the most important pharmaceutical developments of our time, including the COVID-19 vaccine.  But with that partnership, however, there comes a catch. According to the Bayh–Dole Act, if a business organization takes funding from the federal government in order to develop a new product, the U.S. government has the right to “march in” and control w...
Source: TIME: Health - December 8, 2023 Category: Consumer Health News Authors: Anna Gordon Tags: Uncategorized Joe Biden Source Type: news

Emergent BioSolutions to Lay Off About 400 Employees Emergent BioSolutions to Lay Off About 400 Employees
Emergent BioSolutions on Tuesday decided to cut 400 jobs, pivoting its focus on core products such as overdose reversal nasal spray Narcan and anthrax vaccines.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 9, 2023 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Nigeria: Govt Supports Lagos Govt With 50,000 Doses of Anthrax Vaccines
[Vanguard] As fight against outbreak of dreaded Anthrax disease intensifies, the Federal Government has supported the Lagos State Government with 50,000 doses of Anthrax vaccines. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 8, 2023 Category: African Health Tags: Governance Health and Medicine Nigeria West Africa Source Type: news

FDA Approves Emergent BioSolutions' Anthrax Vaccine FDA Approves Emergent BioSolutions' Anthrax Vaccine
Emergent BioSolutions said on Thursday the US Food and Drug Administration has approved its anthrax vaccine for use in adults aged 18 through 65.Reuters Health Information (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - July 22, 2023 Category: Infectious Diseases Tags: Infectious Diseases News Alert Source Type: news

Convictions Over Bleach 'Cure'; FDA OKs Anthrax Vaccine; WHO Donations Draw Scrutiny
(MedPage Today) -- Note that some links may require subscriptions. A Florida father and his three sons were convicted of selling a toxic bleach solution as a "miracle" disease cure via a fake church website. (Miami Herald) The FDA approved an... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - July 21, 2023 Category: American Health Source Type: news

Emergent wins FDA approval of anthrax vaccine Cyfendus
(Source: Reuters: Health)
Source: Reuters: Health - July 20, 2023 Category: Consumer Health News Source Type: news

FDA Approves Cyfendus (Anthrax Vaccine Adsorbed, Adjuvanted) Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use
GAITHERSBURG, Md., July 20, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that the U.S. Food and Drug Administration (FDA) has approved Cyfendus (Anthrax Vaccine Adsorbed, Adjuvanted), previously known as AV7909, for... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 20, 2023 Category: Drugs & Pharmacology Source Type: news

Opioid Antidote Narcan May Soon Be Sold Over the Counter
WASHINGTON — The overdose-reversing drug naloxone should be made available over the counter to aid the national response to the opioid crisis, U.S. health advisers said Wednesday. The panel of Food and Drug Administration experts voted unanimously in favor of the switch after a full day of presentations and discussions centered on whether untrained users would be able to safely and effectively use the nasal spray in emergency situations. The positive vote, which is not binding, came despite concerns from some panel members about the drug’s instructions and packaging, which caused confusion among some people in ...
Source: TIME: Health - February 16, 2023 Category: Consumer Health News Authors: Matthew Perrone/AP Tags: Uncategorized Drugs healthscienceclimate wire Source Type: news

RECOMMENDATIONS AND REPORTS: CDC Guidelines for the Prevention and Treatment of Anthrax, 2023
This report describes updated guidelines and recommendations for prevention and treatment of anthrax. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 6, 2023 Category: American Health Tags: Anthrax Anthrax Vaccination MMWR Morbidity & Mortality Weekly Report Source Type: news

U.S. weighs crackdown on experiments that could make viruses more dangerous
.news-article__hero--featured .parallax__element{ object-position: 50% 40%; -o-object-position: 50% 40%; } .scroll-wrapper { overflow-x: auto; } .scroll-wrapper .news-article__figure__image{ width: 2680px; max-width: none; padding-bottom: .75rem; } .scroll-fade-before, .scroll-fade-after { position: absolute; width: 1.5rem; transition-duration: .1s; opacity: 1; } .scroll-fade-before { left: 1rem; /*margin-left: -1px;*/ background: linear-gradient(90deg, #fff, #fff 35%, hsla(0, 0%, 100%, 0)); } .scroll-fade-after { right: 1rem; /*margin-right: -1px;*/ background: linear-gradient(270deg, #fff, #fff 3...
Source: ScienceNOW - October 19, 2022 Category: Science Source Type: news

Monkeypox Testing Shows the U.S. Learned Little from the COVID-19 Pandemic
U.S. testing for monkeypox is insufficient to determine how widespread the virus is and where new cases are cropping up, according to infectious disease experts and advocates concerned about a sluggish response to the outbreak that’s already hit 32 countries. While government labs have the capacity to test as many as 8,000 samples a week, they’re only using 2% of that capability, suggesting that about 23 monkeypox tests are being performed a day, said James Krellenstein, the cofounder of PrEP4All, an HIV advocacy group that widened its focus during the pandemic. Much more testing is needed to find out where the...
Source: TIME: Health - June 16, 2022 Category: Consumer Health News Authors: Madison Muller / Bloomberg Tags: Uncategorized COVID-19 healthscienceclimate News Desk wire Source Type: news

Fuad El-Hibri, founder of vaccine maker Emergent BioSolutions, dies at 64
A major producer of vaccines against anthrax, the biotech company later attracted scrutiny when it was forced to discard 75 million doses of coronavirus vaccine because of possible contamination. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - May 4, 2022 Category: Consumer Health News Authors: Emily Langer Source Type: news

Fuad El-Hibri, Who Led a Troubled Vaccine Maker, Dies at 64
His company, Emergent BioSolutions, won a lucrative contract to produce Covid vaccines but then had to throw out millions of contaminated doses. (Source: NYT Health)
Source: NYT Health - May 2, 2022 Category: Consumer Health News Authors: Clay Risen Tags: El-Hibri, Fuad Deaths (Obituaries) Emergent BioSolutions Inc Vaccination and Immunization Coronavirus (2019-nCoV) Anthrax Drugs (Pharmaceuticals) United States Politics and Government AstraZeneca PLC Johnson & Source Type: news